JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B5879 GSK2879552
1 Citation

Target: LSD

Summary: Novel and irreversible LSD1 inhibitor

insoluble in EtOH; ≥10.14 mg/mL
B5889 EGF816
2 Citation

Target: EGFR

Summary: Novel covalent inhibitor of mutant-selective EGFR

Soluble in DMSO
B6185 ACP-196

Target: BTK

Summary: irreversible BTK inhibitor

≥46.6 mg/mL
B1104 AZD-9291
1 Citation

Target: EGFR

Summary: Mutated forms EGFR inhibitor

≥24.98 mg/mL
B2083 Caspofungin Acetate
1 Citation

Summary: lipopeptide antifungal drug

≥60.67 mg/mL
B1343 Phenoxybenzamine HCl

Summary: Adrenergic receptor antagonist

insoluble in H2O; ≥17.02 mg/mL
A2571 Pepstatin A
1 Citation

Target: Cathepsins|Renin|HIV proteases|Pepsins

Summary: Aspartic protease inhibitor

≥34.3 mg/mL
B7443 (5Z)-7-Oxozeaenol
1 Citation

Target: TAK1

Summary: TAK1 mitogen-activated protein kinase kinase kinase (MAPKKK) inhibitor

<9.06 mg/mL
B5602 GGsTop

Summary: γ-glutamyl transpeptidase (GGT) inhibitor, novel and irreversible

<6.63 mg/mL
A8170 Z-FA-FMK

Target: cysteine protease

Summary: Cysteine proteases inhibitor

insoluble in H2O; ≥13.45 mg/mL